Contact Us     |

AKCEA PHARMA

Hereditary transthyretin amyloidosis (hATTR): Genetic modifiers and potential biomarkers

Organizer: Akcea Therapeutics

Speakers: Dr. Teresa Coelho, Responsible for the Corino de Andrade unit, Centro Hospitalar do Porto. Reference Center for Family Paramyloidosis.

Prof. Carolina Lemos, i3S, Instituto de Investigação e Inovação em Saúde, Universidade do Porto; UnIGENe, IBMC, Instituto de Biologia Molecular e Celular, Universidade do Porto; ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto.

Prof. Maria João Saraiva, Molecular Neurobiology Group, i3S- Instituto de Investigação e Inovação em Saúde& IBMC- Instituto de Biologia Molecular e Celular

Day: Friday 24th May, 12:30h to 14:00h
Meeting room: Meeting room Petipa, Hotel Vila Gale (Congress venue 1)
Admission: Limited seats to 55

Friday 24th May

12.30h - 14.00 Hereditary transthyretin amyloidosis (hATTR): Genetic modifiers and potential biomarkers.

Chairs : Names, city and country

Challenges in the clinical follow-up of patients with hATTR.

Teresa Coelho (Porto, Portugal)

Genetic modifiers and age-at-onset variation in TTR-FAP Val30Met.

Carolina Lemos (Porto, Portugal)

Animal models of transthyretin amyloidosis to search for FAP patient´s biomarkers. Maria João Saraiva (Porto, Portugal)